Skip to content
Homepage
Author:
Ocugen
Posted Date:
July 1, 2026
Ocugen to Participate in Upcoming July Industry Conferences
Ocugen
July 1, 2026
Ocugen to Participate in Upcoming June Investor and Industry Conferences
Ocugen
June 2, 2026
Ocugen, Inc. Announces Closing for $130.0 Million of 6.75% Convertible Senior Notes
Ocugen
May 27, 2026
Ocugen to Participate in Upcoming May Scientific and Investor Conferences
Ocugen
May 27, 2026
Ocugen Provides Business Update with First Quarter 2026 Financial Results
Ocugen
May 26, 2026
Ocugen, Inc. Announces Pricing of $115 Million of 6.75% Convertible Senior Notes
Ocugen
May 26, 2026
Ocugen Announces Private Offering of $115 Million of Convertible Senior Notes
Ocugen
May 26, 2026
Ocugen to Host Conference Call on Tuesday, May 5 at 8:30 A.M. ET to Discuss Business Updates and First Quarter 2026 Financial Results
Ocugen
May 25, 2026
Ocugen to Present at April 2026 Investor and Industry Conferences
Ocugen
May 24, 2026
Ocugen Announces Early Completion of Dosing in Phase 2/3 Pivotal Confirmatory Trial of OCU410ST for Stargardt Disease
Ocugen
May 22, 2026
1
2
Next
